AlphaFold predicted structure
USB1 · Q9BQ65

Mean pLDDT
82.9/ 100
Confident
265 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)15%
- Low(50–70)7%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
U6 snRNA biogenesis phosphodiesterase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalPigmentary skin disorders
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalpoikiloderma with neutropenia
dyskeratosis congenita
hereditary disease
metabolic disease
chronic obstructive pulmonary disease
Decreased total neutrophil count
neutropenia
Sepsis
Rothmund-Thomson syndrome
pontocerebellar hypoplasia type 7
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
U6 snRNA phosphodiesterase 1
3'-5' RNA exonuclease that trims the 3' end of oligo(U) and oligo(A) tracts of the pre-U6 small nuclear RNA (snRNA) molecule, leading to the formation of a mature U6 snRNA 3' end-terminated with a 2',3'-cyclic phosphate (PubMed:22899009, PubMed:23022480, PubMed:23190533, PubMed:26213367, PubMed:28887445, PubMed:30215753, PubMed:31832688). Participates in the U6 snRNA 3' end processing that prevents U6 snRNA degradation (PubMed:22899009, PubMed:23022480, PubMed:23190533, PubMed:26213367, PubMed:28887445, PubMed:30215753, PubMed:31832688). In addition also removes uridines from the 3' end of U6atac snRNA and possibly the vault RNA VTRNA1-1 (PubMed:26213367)
USB1 · Q9BQ65

Mean pLDDT
82.9/ 100
Confident
265 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0